These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 21596683)
21. Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study. Stryjewski ME; Chu VH; O'Riordan WD; Warren BL; Dunbar LM; Young DM; Vallée M; Fowler VG; Morganroth J; Barriere SL; Kitt MM; Corey GR; Antimicrob Agents Chemother; 2006 Mar; 50(3):862-7. PubMed ID: 16495243 [TBL] [Abstract][Full Text] [Related]
22. [Treatment of lower respiratory tract infections in elderly]. Iakovlev SV Ter Arkh; 1997; 69(12):57-63. PubMed ID: 9503539 [No Abstract] [Full Text] [Related]
23. Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia. Pfaller MA; Mendes RE; Sader HS; Jones RN J Antimicrob Chemother; 2010 Nov; 65(11):2396-404. PubMed ID: 20846936 [TBL] [Abstract][Full Text] [Related]
24. Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin. Nailor MD; Sobel JD Infect Dis Clin North Am; 2009 Dec; 23(4):965-82, ix. PubMed ID: 19909893 [TBL] [Abstract][Full Text] [Related]
25. Vancomycin-resistant Enterococci. Prevalence and risk factors for fecal carriage in patients at tertiary care hospitals. El-Amin NM; Faidah HS Saudi Med J; 2011 Sep; 32(9):966-7. PubMed ID: 21894365 [No Abstract] [Full Text] [Related]